Citation Impact
Citing Papers
A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression
2005 StandoutNobel
ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer–Containing Antibody–Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies
2016
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Arid5a Promotes Immune Evasion by Augmenting Tryptophan Metabolism and Chemokine Expression
2021 StandoutNobel
Neutrophils Are a Key Component of the Antitumor Efficacy of Topical Chemotherapy with Ingenol-3-Angelate
2006
Serum trace elements and Cu/Zn ratio in breast cancer patients
1991
The HSP90 inhibitor 17-AAG synergizes with doxorubicin and U0126 in anaplastic large cell lymphoma irrespective of ALK expression
2006
Suppressor of cytokine signaling 3 expression in anaplastic large cell lymphoma
2004
Myeloid-derived suppressor cells coming of age
2018 Standout
Phagocytes as Corrupted Policemen in Cancer-Related Inflammation
2015
Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy
2009
Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large‐cell lymphoma and inflammatory myofibroblastic tumor
2002
TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors
2000 Standout
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
Putative Mechanism for Anticancer and Apoptosis‐Inducing Properties of Plant‐Derived Polyphenolic Compounds
2000
Management of gram-positive bacterial infections in patients with cancer
2011
Molecular classification of T-cell lymphomas
2009
Natural products: An evolving role in future drug discovery
2011 Standout
Oxidative breakage of cellular DNA by plant polyphenols: A putative mechanism for anticancer properties
2007
Anaplastic lymphoma kinase proteins in growth control and cancer
2004
Inflammatory Myofibroblastic Tumor
2007 Standout
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
2007 StandoutNature
Head and neck cancer
2008 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Inflammatory myofibroblastic tumours: where are we now?
2007 Standout
Effect of Mechanical Ventilation on Inflammatory Mediators in Patients With Acute Respiratory Distress Syndrome
1999 Standout
Network medicine: a network-based approach to human disease
2010 Standout
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Crizotinib inALK-Rearranged Inflammatory Myofibroblastic Tumor
2010 Standout
ALK-1 Expression in Inflammatory Myofibroblastic Tumor of the Urinary Bladder
2004
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning
2002 Standout
Assessment of t(2;5)(p23;q35) Translocation and Variants in Pediatric ALK+ Anaplastic Large Cell Lymphoma
2004
Anaplastic Large Cell Lymphoma
2007
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Inflammatory myofibroblastic tumor in children: clinical review with anaplastic lymphoma kinase, Epstein-Barr virus, and human herpesvirus 8 detection analysis
2005
The Nucleophosmin-Anaplastic Lymphoma Kinase Fusion Protein Induces c-Myc Expression in Pediatric Anaplastic Large Cell Lymphomas
2002
EORTC Classification for Primary Cutaneous Lymphomas: The Best Guide to Good Clinical Management
1999
Differential Expression of BCL-2 Family Proteins in ALK-Positive and ALK-Negative Anaplastic Large Cell Lymphoma of T/Null-Cell Lineage
2001
Targeting apoptosis in cancer therapy
2020 Standout
Crizotinib (PF-2341066) induces apoptosis due to downregulation of pSTAT3 and BCL-2 family proteins in NPM-ALK+ anaplastic large cell lymphoma
2014
Tumour-associated neutrophils in patients with cancer
2019
p16(MTS-1/CDKN2/INK4a) in Cancer Progression
2001
Cutaneous Manifestations of Lymphoma: A Clinical Guide Based on the WHO Classification
2001
Gender and age-related differences in Burkitt lymphoma – epidemiological and clinical data from The Netherlands
2004
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Aspergillosis Case-Fatality Rate: Systematic Review of the Literature
2001 Standout
Epstein–Barr virus: 40 years on
2004 Standout
Resveratrol Mobilizes Endogenous Copper in Human Peripheral Lymphocytes Leading to Oxidative DNA Breakage: A Putative Mechanism for Chemoprevention of Cancer
2010
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
SOCS regulation of the JAK/STAT signalling pathway
2008 Standout
Activation of apoptosis signalling pathways by reactive oxygen species
2016 Standout
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
p53 mutation and MDM2 amplification in inflammatory myofibroblastic tumours
2003
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia
2001
TNF-related apoptosis-inducing ligand (TRAIL): A new path to anti-cancer therapies
2009
The STATs of cancer — new molecular targets come of age
2004 Standout
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
2003 Standout
MYC Alterations in Diffuse Large B-Cell Lymphomas
2015
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
2020
CURCUMIN: THE INDIAN SOLID GOLD
2007 Standout
Cancer and the chemokine network
2004 Standout
Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution
2008
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia
2003
Multiple Functions of Jab1 Are Required for Early Embryonic Development and Growth Potential in Mice
2004 StandoutNobel
Biological effects of essential oils – A review
2007 Standout
STATs: transcriptional control and biological impact
2002 Standout
Peripheral T- cell lymphomas: diagnosis and management
2003
Gallic acid: a versatile antioxidant with promising therapeutic and industrial applications
2015 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Trends in survival of patients with Burkitt lymphoma/leukemia in the USA: an analysis of 3691 cases
2013
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)
2013 Standout
Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis
2014
Detection of differentially expressed genes in lymphomas using cDNA arrays: identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas
2000
2016 US lymphoid malignancy statistics by World Health Organization subtypes
2016 Standout
Primary and secondary cutaneous CD30+lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment
2000
Soluble receptors in human disease
1998
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Properties of Resveratrol:In VitroandIn VivoStudies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans
2015 Standout
Intensified and Shortened Cyclical Chemotherapy for Adult Acute Lymphoblastic Leukemia
2002
Survivin Expression Predicts Poorer Prognosis in Anaplastic Large-Cell Lymphoma
2004
Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry
2002
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia
2013
Multilevel Dysregulation of STAT3 Activation in Anaplastic Lymphoma Kinase-Positive T/Null-Cell Lymphoma
2002
In vivo T-cell immune response against anaplastic lymphoma kinase in patients with anaplastic large cell lymphomas.
2006
Invasive aspergillosis in neutropenic patients: rapid neutrophil recovery is a risk factor for severe pulmonary complications
1999
Survival and Clonal Expansion of Mutating “Forbidden” (Immunoglobulin Receptor–Deficient) Epstein-Barr Virus–Infected B Cells in Angioimmunoblastic T Cell Lymphoma
2001
Effusion-associated anaplastic large cell lymphoma of the breast: time for it to be defined as a distinct clinico-pathological entity
2010
Expression of p27(Kip1) and c-Jun activation binding protein 1 are inversely correlated in systemic anaplastic large cell lymphoma.
2003
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches
2016 Standout
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Anaplastic lymphoma kinase: signalling in development and disease
2009
Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas.
2004
The role of cytokines in classical Hodgkin lymphoma
2002
Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: 2 cases expressing ALK kinase fused to CLTCL (clathrin chain polypeptide-like)
2000
Lymphomas expressing ALK fusion protein(s) other than NPM-ALK.
1999
Cancer treatment and survivorship statistics, 2014
2014 Standout
Preventing and Managing Toxicities of High-Dose Methotrexate
2016 Standout
Works of Giuseppe Todeschini being referenced
Immunologic abnormalities in angioimmunoblastic lymphadenopathy
1987
High-Dose Anthracycline Induction in Adult Acute Lymphocytic Leukemia
2001
Follow-Up of Superoxide Production by Phagocytes in Whole Blood of Leukaemic Patients during Therapy
1988
Molecular features of primary mediastinal B‐cell lymphoma: involvement of p16INK4A, p53 and c‐myc
1999
Soluble interleukin-2 receptor in hairy-cell leukemia: a reliable marker of disease
1993
Intensive short‐term chemotherapy regimen induces high remission rate (over 90%) and event‐free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia
2011
Serum levels of soluble interleukin-2 receptor in Hodgkin disease. Relationship with clinical stage, tumor burden, and treatment outcome
1993
Association between Enterococcus bacteraemia and death in neutropenic patients with haematological malignancies
2006
IFNα-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells
2004
Empiric Therapy of Infections in Hematologic Malignancies: A Prospective, Randomized Trial
1983
ALK+ lymphoma: clinico-pathological findings and outcome.
1999
Relationship between Daunorubicin dosage delivered during induction therapy and outcome in adult acute lymphoblastic leukemia.
1994
The Diagnostic Value of Serum Copper Levels and other Hematochemical Parameters in Malignancies
1978
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients
2016